Merck
Executive Director, Medical Affairs, Oncology - Breast
Merck, Albany, New York, United States
Overview
The Executive Director (ED) for US Medical Affairs (USMA) understands Our Company’s enterprise level strategies and leads cross-functionally with the Global Medical and Scientific Affairs Therapeutic Area (GMSA TA) teams to translate Global Value and implementation (V&I) goals into the relevant US country-level goals and priorities.
The USMA ED level of responsibility and accountability is in alignment with the USMA core vision of advancing medical innovations that improve patient outcomes in the US and setting the foundation for impact around the globe. Thus, the USMA ED is responsible for the creation and execution of the overall therapeutic aligned US strategy and Country-Medical Affairs Plans (CMAP).
The USMA ED is also responsible for the Strategic Scientific Engagement Plan for the US, including tactical execution by the field Regional Medical Scientific Director (RMSD) teams and is accountable for ensuring field teams execute on Integrated Field Medical Plans (FMPs) to achieve field medical priorities in alignment the Scientific Exchange Field Medical Policy. The ED will focus half of their time leading US/Global strategic TA needs and the other half of their time leading and managing the US RMSD Field Medical strategy and execution.
#J-18808-Ljbffr
The USMA ED level of responsibility and accountability is in alignment with the USMA core vision of advancing medical innovations that improve patient outcomes in the US and setting the foundation for impact around the globe. Thus, the USMA ED is responsible for the creation and execution of the overall therapeutic aligned US strategy and Country-Medical Affairs Plans (CMAP).
The USMA ED is also responsible for the Strategic Scientific Engagement Plan for the US, including tactical execution by the field Regional Medical Scientific Director (RMSD) teams and is accountable for ensuring field teams execute on Integrated Field Medical Plans (FMPs) to achieve field medical priorities in alignment the Scientific Exchange Field Medical Policy. The ED will focus half of their time leading US/Global strategic TA needs and the other half of their time leading and managing the US RMSD Field Medical strategy and execution.
#J-18808-Ljbffr